Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)
US9989519B1 · kind B1 · utility
0Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2017 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | May 4, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5044
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides methods for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension RLD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.